Clinical nurse specialist and evidence-based practice: Managing anthracycline extravasation

Journal of Pediatric Oncology Nursing

Volumn 22, Issue 5, 2005, Pages 261-264

  Hooke, Mary C ^a,b,c  

^a Children's Hospitals and Clinics Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

Author keywords

Anthracycline extravasation; Clinical nurse specialist; Evidence based practice

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC ANTIBIOTIC; CHELATING AGENT; DOXORUBICIN; RAZOXANE;

ADOLESCENT; CASE REPORT; CONTRAST MEDIUM EXTRAVASATION; DEBRIDEMENT; EVIDENCE BASED MEDICINE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NURSE; NURSING; REVIEW;

ADOLESCENT; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; CHELATING AGENTS; DEBRIDEMENT; DOXORUBICIN; EVIDENCE-BASED MEDICINE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HUMANS; INFUSIONS, INTRAVENOUS; NURSE CLINICIANS; RAZOXANE;

EID: 25144484879     PISSN: 10434542     EISSN: None     Source Type: Journal    
DOI: 10.1177/1043454205279289     Document Type: Review

References (12)

1. American Nurses Association. (2004). Nursing: Scope and standards of practice. Washington, DC: American Nurses Publishing.
2. American Nurses Credentialing Center. (2005). Clinical nurse specialist certification. ANCC certification. Retrieved June 2, 2005, from http://www.nursingworld.org/ancc/certification/cert/certs/advprac/cns.html
3. Banerjee, A., Brotherston, T. M., Lamberty, B. G. H., & Campbell, R. C. (1987). Cancer chemotherapy agent-induced perivenous extravasation injuries. Postgraduate Medical Journal, 63, 5-9.
4. Camp-Sorrell, D. (1998). Developing extravasation protocols and monitoring outcomes. Journal of Intravenous Nursing, 21, 232-239.
5. Fulton, J. S. (2004). The fruits of new knowledge. Clinical Nurse Specialist, 18, 55-56.
6. Hadorn, D. C., Baker, D., Hodges, J. S., & Hicks, N. (1996). Rating the quality of evidence for clinical practice guidelines. Journal of Clinical Epidemiology, 49, 49-75.
7. Heitkemper, M. M., & Bond, E. F. (2004). Clinical nurse specialists: State of the profession and challenges ahead. Clinical Nurse Specialist, 18, 135-140.
8. Kassner, E. (2000). Evaluation and treatment of chemotherapy extravasation injuries. Journal of Pediatric Oncology Nursing, 17, 135-149.
9. Langer, S. W., Sehested, M., and Jensen, P. B. (2000). Treatment of anthracycline extravasation with dexrazoxane. Clinical Cancer Research, 6, 3680-3686.
10. Langer, S. W., Sehested, M., Jensen, P. B., Buter, J., & Giaccone, G. (2000). Dexrazoxane in anthracycline extravasation. Journal of Clinical Oncology, 18, 3064.
11. Micromedex. (2005). Doxorubicin, cautions, adverse reactions, adverse reactions skin, extravasation. Micromedex Healthcare Series. Retrieved June 2, 2005, from http://medexmps.childrenshc.org/mdxcgi/display.exe?CTL=D:\mdx\mdxcgi\ MEGAT.SYS&SET=1C56B6CB822DE200&SYS=1&T=677&D=1328
12. Van Beek, A., McDonough, E., & Hooke, C. (2003, May). 15 YO with Hodgkin's disease: Extravasation of doxorubicin. Paper presented at the Children's Hospitals and Clinics-Minnesota Oncology Tumor Conference.